1r3c
|
THE STRUCTURE OF P38ALPHA C162S MUTANT
OverviewOverview
Mitogen-activated protein (MAP) kinase p38 alpha is activated in response, to environmental stress and cytokines, and plays a significant role in, inflammatory responses. For these reasons, it is an important target for, the treatment of a wide range of inflammatory and autoimmune diseases. The, crystals of p38 alpha that we obtained by published procedures were, usually small, quite mosaic, and difficult to reproduce and thus posed a, difficulty for the intensive high-resolution studies required for a, structure-guided drug discovery approach. Based on crystallographic and, biochemical evidences, we prepared a single point mutation of a surface, cysteine (C162S) and found that it prevents aggregation and improves the, homogeneity and stability of the enzyme. This mutation also facilitates, the crystallization process and increases the diffracting power of p38, alpha crystals. Surprisingly, we found that the mutation induces a change, in the conformation of a nearby surface loop resulting in stronger lattice, interactions, consistent with the improved crystal quality. The mutant, protein, because of its improved stability and strengthened lattice, interactions, thus provides a significantly improved reagent for use in, structure-based drug design for this important disease target.
About this StructureAbout this Structure
1R3C is a Single protein structure of sequence from Homo sapiens with MG as ligand. Active as Non-specific serine/threonine protein kinase, with EC number 2.7.11.1 Full crystallographic information is available from OCA.
ReferenceReference
Lattice stabilization and enhanced diffraction in human p38 alpha crystals by protein engineering., Patel SB, Cameron PM, Frantz-Wattley B, O'Neill E, Becker JW, Scapin G, Biochim Biophys Acta. 2004 Jan 14;1696(1):67-73. PMID:14726206
Page seeded by OCA on Mon Nov 12 18:59:16 2007